MAP2K7 and neoplasm: In addition, the effectiveness of MEK and PI3K inhibitors in reducing peritoneal tumor growth will need to be tested in MCA patient-derived xenograft mouse models as such models more faithfully recapitulate the tumor heterogeneity seen in human cancers than cell line-derived xenograft models.